Fig 1: O-xylose-associated factors promote IAV replication in A549 cells. (A) Schematic diagram of HS chain elongation of heparan sulfate proteoglycans (HSPGs). Xyl, xylose; Gal, galactose; GlcA, glucuronic acid; GlcNAc, N-acetylglucosamine. (B and C) A549 cells transfected with plasmids expressing XYLT2-Myc or B4GALT7-Myc (B) or co-transfected with plasmids expressing EXT1-Myc and EXT2-HA (C) were fixed at 24 hours post-transfection, incubated with a mouse anti-Myc mAb and a rabbit anti-CANX pAb or a rabbit anti-GM130 pAb (B) or with a mouse anti-HA mAb and a rabbit anti-Myc pAb (C), and stained with Alexa Fluor 633 goat anti-mouse IgG (H+L) (red) and Alexa Fluor 488 goat anti-rabbit IgG (H+L) (green). (D) The XYLT2 protein level was detected by Western blotting in A549 cells transfected with XYLT2 siRNA or scrambled siRNA for 48 hours. (E) Virus titers in XYLT2-knockdown A549 cells infected with the WSN (H1N1) virus (MOI = 0.01) at the indicated time points (n = 3 biologically independent samples). ***, P < 0.001. (F) A549 cells were transfected with B4GALT7 siRNA or scrambled siRNA for 12 hours and further transfected with plasmids expressing B4GALT7-HA for 24 hours. The B4GALT7 protein level was evaluated by Western blotting. (G) Virus titers in B4GALT7-knockdown A549 cells infected with the WSN (H1N1) virus (MOI = 0.01) at the indicated time points (n = 3 biologically independent samples). ***, P < 0.001. (H, I) EXT1 (H) or EXT2 (I) protein levels detected by Western blotting in A549 cells transfected with EXT1 siRNA, EXT2 siRNA, or scrambled siRNA for 48 hours. (J) Virus titers in EXT1- or EXT2-knockdown A549 cells infected with WSN (H1N1) virus (MOI = 0.01) at the indicated time points (n = 3 biologically independent samples). *, P < 0.05; **, P < 0.01. (K) A549 cells co-transfected with plasmids expressing SLC35B4-Myc and XYLT2-HA, B4GALT7-HA, or EXT1/EXT2-HA were fixed at 24 hours post-transfection, incubated with a mouse anti-HA mAb and a rabbit anti-Myc pAb, and stained with Alexa Fluor 633 goat anti-mouse IgG (H+L) (red) and Alexa Fluor 488 goat anti-rabbit IgG (H+L) (green).
Fig 2: SLC35B4-mediated HS modification of AGRN promotes IAV internalization into host cells. (A) SLC35B4 transports UDP-xylose from the cytoplasm to the endoplasmic reticulum (ER), XYLT2 catalyzes UDP-xylose coupling with the serine residue of HS-modified protein AGRN, and B4GALT7-EXT1/EXT2 catalyzes the HS chain elongation of AGRN. The HS-modified AGRN protein is transported to the plasma membrane, binds the viral HA protein, and further recruits the endocytic adapter AP2B1 to initiate virus endocytosis. (B) Excessive accumulation of the unmodified AGRN HS mutant due to the deficiency in SLC35B4 expression leads to AP2B1 degradation via the proteasome pathway, thereby inhibiting the endocytosis of IAV.
Supplier Page from Abcam for Anti-XYLT2 antibody